Prevalence of Cancer in Patients with Venous Thromboembolism: A Retrospective Nationwide Case-Control Study in Sweden

Cancer is a risk factor for venous thromboembolism (VTE). We aimed to define sex-specific risk of preceding cancer in patients with a first-time VTE by conducting a nationwide Swedish registry-based study including 298 172 patients with VTE and 1 185 079 matched controls. This included 44 685 patien...

Full description

Saved in:
Bibliographic Details
Published inClinical and applied thrombosis/hemostasis Vol. 29; p. 10760296231158368
Main Authors Glise Sandblad, Katarina, Hansson, Per-Olof, Philipson, Jacob, Mahmoud, Ahmad, Karlsson, Per, Rosengren, Annika, Sörbo, Jan
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.01.2023
SAGE PUBLICATIONS, INC
SAGE Publishing
Subjects
Brain cancer
Cancer and Oncology
Cancer och onkologi
Carcinoma, Renal Cell
Case-Control Studies
Clinical Medicine
Cross-sectional studies
Epidemiology
Female
Frailty
Health risks
Humans
Kidney cancer
Kidney Neoplasms
Klinisk medicin
Male
Medical diagnosis
Melanoma
Original Manuscript
Pancreatic cancer
Prevalence
Prostate cancer
Retrospective Studies
Sweden - epidemiology
Thromboembolism
Venous Thromboembolism - epidemiology
Venous Thromboembolism - etiology
Sweden
(MESH): incidence
registry
sex difference
neoplasms
venous thromboembolism
Online AccessGet full text
ISSN1076-0296
1938-2723
1938-2723
DOI10.1177/10760296231158368

Cover

Abstract Cancer is a risk factor for venous thromboembolism (VTE). We aimed to define sex-specific risk of preceding cancer in patients with a first-time VTE by conducting a nationwide Swedish registry-based study including 298 172 patients with VTE and 1 185 079 matched controls. This included 44 685 patients with a diagnosis of cancer at/or within 1 year before a VTE diagnosis. Female patients with VTE had a higher multivariable adjusted odds ratios of preceding cancer than male patients with VTE (5.5 [99% confidence interval 5.4-5.7] vs 3.9 [3.8-4.0]). The highest risk of cancer in patients with VTE were found for pancreatic cancer (women: 19.6 [15.8-24.4]; men: 17.2 [13.7-21.6]) and brain cancer (women: 17.4 [12.9-23.4]; men: 17.5 [13.8-22.2]). Weak associations were seen between VTE and bladder/urothelial cancer (women: 1.31 [1.12-1.53]; men: 1.34 [1.23-1.47]), prostate cancer (men: 2.17 [2.07-2.27]), malignant melanoma (women: 2.51 [2.07-3.05]; men: 2.67 [2.23-3.18]), and kidney cancer (women: 3.20 [2.49-4.11]; men: 3.33 [2.79-4.07]). In conclusion, associations with VTE were weak for bladder/urothelial cancer and kidney cancer, and strong for pancreatic, brain, and biliary cancers.
AbstractList Cancer is a risk factor for venous thromboembolism (VTE). We aimed to define sex-specific risk of preceding cancer in patients with a first-time VTE by conducting a nationwide Swedish registry-based study including 298172 patients with VTE and 1185079 matched controls. This included 44685 patients with a diagnosis of cancer at/or within 1 year before a VTE diagnosis. Female patients with VTE had a higher multivariable adjusted odds ratios of preceding cancer than male patients with VTE (5.5 [99% confidence interval 5.4-5.7] vs 3.9 [3.8-4.0]). The highest risk of cancer in patients with VTE were found for pancreatic cancer (women: 19.6 [15.8-24.4]; men: 17.2 [13.7-21.6]) and brain cancer (women: 17.4 [12.9-23.4]; men: 17.5 [13.8-22.2]). Weak associations were seen between VTE and bladder/urothelial cancer (women: 1.31 [1.12-1.53]; men: 1.34 [1.23-1.47]), prostate cancer (men: 2.17 [2.07-2.27]), malignant melanoma (women: 2.51 [2.07-3.05]; men: 2.67 [2.23-3.18]), and kidney cancer (women: 3.20 [2.49-4.11]; men: 3.33 [2.79-4.07]). In conclusion, associations with VTE were weak for bladder/urothelial cancer and kidney cancer, and strong for pancreatic, brain, and biliary cancers.
Cancer is a risk factor for venous thromboembolism (VTE). We aimed to define sex-specific risk of preceding cancer in patients with a first-time VTE by conducting a nationwide Swedish registry-based study including 298 172 patients with VTE and 1 185 079 matched controls. This included 44 685 patients with a diagnosis of cancer at/or within 1 year before a VTE diagnosis. Female patients with VTE had a higher multivariable adjusted odds ratios of preceding cancer than male patients with VTE (5.5 [99% confidence interval 5.4-5.7] vs 3.9 [3.8-4.0]). The highest risk of cancer in patients with VTE were found for pancreatic cancer (women: 19.6 [15.8-24.4]; men: 17.2 [13.7-21.6]) and brain cancer (women: 17.4 [12.9-23.4]; men: 17.5 [13.8-22.2]). Weak associations were seen between VTE and bladder/urothelial cancer (women: 1.31 [1.12-1.53]; men: 1.34 [1.23-1.47]), prostate cancer (men: 2.17 [2.07-2.27]), malignant melanoma (women: 2.51 [2.07-3.05]; men: 2.67 [2.23-3.18]), and kidney cancer (women: 3.20 [2.49-4.11]; men: 3.33 [2.79-4.07]). In conclusion, associations with VTE were weak for bladder/urothelial cancer and kidney cancer, and strong for pancreatic, brain, and biliary cancers.Cancer is a risk factor for venous thromboembolism (VTE). We aimed to define sex-specific risk of preceding cancer in patients with a first-time VTE by conducting a nationwide Swedish registry-based study including 298 172 patients with VTE and 1 185 079 matched controls. This included 44 685 patients with a diagnosis of cancer at/or within 1 year before a VTE diagnosis. Female patients with VTE had a higher multivariable adjusted odds ratios of preceding cancer than male patients with VTE (5.5 [99% confidence interval 5.4-5.7] vs 3.9 [3.8-4.0]). The highest risk of cancer in patients with VTE were found for pancreatic cancer (women: 19.6 [15.8-24.4]; men: 17.2 [13.7-21.6]) and brain cancer (women: 17.4 [12.9-23.4]; men: 17.5 [13.8-22.2]). Weak associations were seen between VTE and bladder/urothelial cancer (women: 1.31 [1.12-1.53]; men: 1.34 [1.23-1.47]), prostate cancer (men: 2.17 [2.07-2.27]), malignant melanoma (women: 2.51 [2.07-3.05]; men: 2.67 [2.23-3.18]), and kidney cancer (women: 3.20 [2.49-4.11]; men: 3.33 [2.79-4.07]). In conclusion, associations with VTE were weak for bladder/urothelial cancer and kidney cancer, and strong for pancreatic, brain, and biliary cancers.
Cancer is a risk factor for venous thromboembolism (VTE). We aimed to define sex-specific risk of preceding cancer in patients with a first-time VTE by conducting a nationwide Swedish registry-based study including 298 172 patients with VTE and 1 185 079 matched controls. This included 44 685 patients with a diagnosis of cancer at/or within 1 year before a VTE diagnosis. Female patients with VTE had a higher multivariable adjusted odds ratios of preceding cancer than male patients with VTE (5.5 [99% confidence interval 5.4-5.7] vs 3.9 [3.8-4.0]). The highest risk of cancer in patients with VTE were found for pancreatic cancer (women: 19.6 [15.8-24.4]; men: 17.2 [13.7-21.6]) and brain cancer (women: 17.4 [12.9-23.4]; men: 17.5 [13.8-22.2]). Weak associations were seen between VTE and bladder/urothelial cancer (women: 1.31 [1.12-1.53]; men: 1.34 [1.23-1.47]), prostate cancer (men: 2.17 [2.07-2.27]), malignant melanoma (women: 2.51 [2.07-3.05]; men: 2.67 [2.23-3.18]), and kidney cancer (women: 3.20 [2.49-4.11]; men: 3.33 [2.79-4.07]). In conclusion, associations with VTE were weak for bladder/urothelial cancer and kidney cancer, and strong for pancreatic, brain, and biliary cancers.
Author Philipson, Jacob
Karlsson, Per
Rosengren, Annika
Sörbo, Jan
Hansson, Per-Olof
Glise Sandblad, Katarina
Mahmoud, Ahmad
AuthorAffiliation 4 Department of Clinical Physiology, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden
2 Department of Medicine, Geriatrics and Emergency Medicine, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden
1 Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden
3 Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University hospital/ Sahlgrenska, Gothenburg University, Gothenburg, Sweden
AuthorAffiliation_xml – name: 1 Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden
– name: 4 Department of Clinical Physiology, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden
– name: 3 Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University hospital/ Sahlgrenska, Gothenburg University, Gothenburg, Sweden
– name: 2 Department of Medicine, Geriatrics and Emergency Medicine, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden
Author_xml – sequence: 1
  givenname: Katarina
  orcidid: 0000-0002-6563-0893
  surname: Glise Sandblad
  fullname: Glise Sandblad, Katarina
– sequence: 2
  givenname: Per-Olof
  surname: Hansson
  fullname: Hansson, Per-Olof
– sequence: 3
  givenname: Jacob
  surname: Philipson
  fullname: Philipson, Jacob
– sequence: 4
  givenname: Ahmad
  surname: Mahmoud
  fullname: Mahmoud, Ahmad
– sequence: 5
  givenname: Per
  surname: Karlsson
  fullname: Karlsson, Per
– sequence: 6
  givenname: Annika
  surname: Rosengren
  fullname: Rosengren, Annika
– sequence: 7
  givenname: Jan
  surname: Sörbo
  fullname: Sörbo, Jan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36851858$$D View this record in MEDLINE/PubMed
https://gup.ub.gu.se/publication/324276$$DView record from Swedish Publication Index
BookMark eNp9kktv1DAQxyNURB_wAbigSFy4pPiR-MEBqVrxqFRBRQtXy3Emu15l7a2ddNVvz2y3BVoEB8vWzP__03hmDou9EAMUxUtKjimV8i0lUhCmBeOUNooL9aQ4oJqriknG9_CN-Wor2C8Oc14SQrXQ4lmxj9KGqkYdFNN5gms7QHBQxr6cWXyk0ofy3I4ewpjLjR8X5Q8Iccrl5SLFVRsBz-Dz6l15Un6DMcW8Bjf6ayi_oCuGje8AURmqWQyYHsqLceputtiLDXQQnhdPeztkeHF3HxXfP364nH2uzr5-Op2dnFWukWSsgNesl5pzySjvOtKC7nXd6hocU4xp16iuVlz3rMX_ANBGKCU5A0ZAMdLzo-J0x-2iXZp18iubbky03twGYpobm0bvBjAcNDaxcY1tXe2osgC27TvbC2olITWyqh0rb2A9tQ9o82ltMDSfTEYSq5kUqH-_06N4BZ3DZiY7PLA9zAS_MPN4bbRWQpMGAW_uACleTZBHs_LZwTDYADgMw6TC-QohKUpfP5Iu45QCttYwzYggdcO3P3j1Z0W_SrnfBhTIncDhSHOC3jg_3k4UC_SDocRs9878tXfopI-c9_D_eY7vGmrn8Lvgfxt-Ahxt5yY
CitedBy_id crossref_primary_10_17650_1726_9776_2024_20_1_164_173
crossref_primary_10_23736_S2724_6051_24_05699_4
crossref_primary_10_1016_j_eclinm_2023_102194
crossref_primary_10_1016_j_euf_2024_02_004
crossref_primary_10_1016_j_jtha_2024_12_016
crossref_primary_10_1002_bco2_481
crossref_primary_10_3390_cancers16234031
Cites_doi 10.2147/PPA.S79373
10.1056/NEJM200012213432504
10.1136/bmjopen-2015-008864
10.1016/j.ejca.2017.07.013
10.1200/JCO.2005.03.8877
10.1016/j.ejca.2012.10.021
10.1182/bloodadvances.2021005590
10.1111/j.1538-7836.2007.02857.x
10.1182/bloodadvances.2020003442
10.1038/s41598-021-91131-4
10.1038/sj.bjc.6605883
10.2147/CEOR.S39964
10.1002/cncr.27772
10.1001/jama.293.6.715
10.1001/archinte.166.4.458
10.1182/blood-2007-10-116327
10.1038/s41572-022-00336-y
10.1002/cncr.23062
10.2147/CLEP.S177058
10.1007/s11136-019-02175-z
10.1002/rth2.12714
10.1182/blood.2020007338
10.1634/theoncologist.2013-0226
10.1093/eurheartj/ehab171
ContentType Journal Article
Copyright The Author(s) 2023
The Author(s) 2023. This work is licensed under the Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023 2023 SAGE Publications Inc. unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
Copyright_xml – notice: The Author(s) 2023
– notice: The Author(s) 2023. This work is licensed under the Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023 2023 SAGE Publications Inc. unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
DBID AFRWT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTPV
AOWAS
F1U
DOA
DOI 10.1177/10760296231158368
DatabaseName SAGE Journals GOLD Open Access 2024
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Göteborgs universitet
DOAJ (Directory of Open Access Journals)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


Publicly Available Content Database
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: AFRWT
  name: Sage Journals GOLD Open Access 2024
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
– sequence: 5
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1938-2723
ExternalDocumentID oai_doaj_org_article_3e91155c5abc4c18aeeabfdaf61a7004
oai_gup_ub_gu_se_324276
PMC9986905
36851858
10_1177_10760296231158368
10.1177_10760296231158368
Genre Journal Article
GeographicLocations Sweden
GeographicLocations_xml – name: Sweden
GrantInformation_xml – fundername: the Swedish state under an agreement between the Swedish government and the county councils concerning economic support of research and education of doctors
  grantid: ALFGBG-942902; ALFGBG-965023; ALFGBG-966211
– fundername: Sahlgrenska University Hospitals Research Foundations
  grantid: SU-971213
  funderid: https://doi.org/10.13039/501100014196
– fundername: Göteborgs Läkaresällskap
  grantid: GLS-961549
  funderid: https://doi.org/10.13039/501100005689
– fundername: Vetenskapsrådet
  grantid: 2019-00193
  funderid: https://doi.org/10.13039/501100004359
– fundername: Hjärt-Lungfonden
  grantid: 2021-0345
  funderid: https://doi.org/10.13039/501100003793
– fundername: ;
  grantid: SU-971213
– fundername: ;
  grantid: 2021-0345
– fundername: ;
  grantid: 2019-00193
– fundername: ;
  grantid: ALFGBG-942902; ALFGBG-965023; ALFGBG-966211
– fundername: ;
  grantid: GLS-961549
GroupedDBID ---
-TM
.2F
.2G
01A
0R~
29B
31S
31Y
36B
4.4
53G
54M
5GY
5VS
7X7
8FI
8FJ
AABMB
AACKU
AADUE
AAGGD
AAJIQ
AAJOX
AAJPV
AANSI
AAPEO
AAQDB
AAQGT
AAQXH
AARDL
AARIX
AASGM
AAXOT
AAYTG
AAZBJ
ABAWP
ABDWY
ABEIX
ABFWQ
ABHKI
ABJIS
ABKRH
ABPGX
ABQKF
ABQXT
ABRHV
ABUWG
ABVFX
ABVVC
ABXGC
ABYTW
ACARO
ACDSZ
ACDXX
ACFMA
ACFYK
ACGBL
ACGFS
ACLHI
ACOFE
ACROE
ACRPL
ADBBV
ADEBD
ADEIA
ADMPF
ADNBR
ADNMO
ADOGD
ADSTG
ADTBJ
ADUKL
ADYCS
ADZZY
AECVZ
AENEX
AEQLS
AERKM
AEUHG
AEWDL
AEXFG
AEXNY
AFCOW
AFEET
AFKBI
AFKRA
AFKRG
AFRWT
AFUIA
AFWMB
AGNHF
AGQPQ
AHHFK
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
B8M
B8O
B93
BDDNI
BENPR
BKSCU
BPHCQ
BSEHC
BVXVI
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
DC-
DC.
DC0
DD-
DD0
DE-
DOPDO
DU5
D~Y
EBS
EJD
EMB
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HMCUK
HVGLF
HYE
HZ~
J8X
K.F
K.J
N9A
O9-
OK1
OVD
P.B
PHGZM
PHGZT
PIMPY
PQQKQ
Q1R
Q7K
Q7R
Q7X
Q82
RIG
ROL
RPM
S01
SAUOL
SCDPB
SCNPE
SFB
SFC
SFN
SGA
SGP
SGX
SQCSI
SV3
TEORI
UKHRP
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
ACHEB
CITATION
-MK
31X
AADTT
AAMGE
AATBZ
ABHQH
ACGZU
ACSBE
ACSIQ
AEUIJ
AEWHI
B8Z
CGR
CUY
CVF
DV7
ECM
EIF
M4V
NPM
SFK
SFT
SGV
SPJ
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
AAEJI
ADTPV
AOWAS
F1U
ID FETCH-LOGICAL-c570t-e342f79337213dd0be9f94b94ec28229c58d4839f2b851ee15688732e20e820f3
IEDL.DBID AFRWT
ISSN 1076-0296
1938-2723
IngestDate Wed Aug 27 01:30:35 EDT 2025
Tue Sep 09 23:23:00 EDT 2025
Thu Aug 21 18:38:10 EDT 2025
Fri Sep 05 12:18:11 EDT 2025
Mon Jun 30 13:14:57 EDT 2025
Thu Jan 02 22:53:09 EST 2025
Thu Apr 24 22:53:30 EDT 2025
Tue Jul 01 05:27:20 EDT 2025
Tue Jun 17 22:28:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords (MESH): incidence
registry
sex difference
neoplasms
venous thromboembolism
Language English
License This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c570t-e342f79337213dd0be9f94b94ec28229c58d4839f2b851ee15688732e20e820f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6563-0893
OpenAccessLink https://journals.sagepub.com/doi/full/10.1177/10760296231158368?utm_source=summon&utm_medium=discovery-provider
PMID 36851858
PQID 2920604534
PQPubID 4450586
ParticipantIDs doaj_primary_oai_doaj_org_article_3e91155c5abc4c18aeeabfdaf61a7004
swepub_primary_oai_gup_ub_gu_se_324276
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9986905
proquest_miscellaneous_2780766671
proquest_journals_2920604534
pubmed_primary_36851858
crossref_citationtrail_10_1177_10760296231158368
crossref_primary_10_1177_10760296231158368
sage_journals_10_1177_10760296231158368
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-01-01
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Los Angeles, CA
PublicationPlace_xml – name: Los Angeles, CA
– name: United States
– name: Thousand Oaks
– name: Sage CA: Los Angeles, CA
PublicationTitle Clinical and applied thrombosis/hemostasis
PublicationTitleAlternate Clin Appl Thromb Hemost
PublicationYear 2023
Publisher SAGE Publications
SAGE PUBLICATIONS, INC
SAGE Publishing
Publisher_xml – name: SAGE Publications
– name: SAGE PUBLICATIONS, INC
– name: SAGE Publishing
References Lyman, Carrier, Ay 2021; 5
Abdul Sultan, West, Stephansson 2015; 5
Khorana, Francis, Culakova, Kuderer, Lyman 2007; 110
Öhman, Johansson, Jansson, Lind, Johansson 2018; 10
Noble, Prout, Nelson 2015; 9
Glise Sandblad, Rosengren, Sörbo, Jern, Hansson 2022; 6
Mahajan, Brunson, Adesina, Keegan, Wun 2022; 6
Radkiewicz, Johansson, Dickman, Lambe, Edgren 2017; 84
Chuang, Gumbs, Van Hout 2019; 28
Mulder, Horváth-Puhó, van Es 2021; 137
Khorana, Dalal, Lin, Connolly 2013; 5
Khorana, Kuderer, Culakova, Lyman, Francis 2008; 111
Khorana, Dalal, Lin, Connolly 2013; 119
Sørensen, Mellemkjaer, Olsen, Baron 2000; 343
Walker, Card, West, Crooks, Grainge 2013; 49
Cronin-Fenton, Søndergaard, Pedersen 2010; 103
Khorana, Francis, Culakova, Fisher, Kuderer, Lyman 2006; 24
Lyman, Eckert, Wang, Wang, Cohen 2013; 18
Scomersi, Giudici, Cacciatore 2021; 11
Chew, Wun, Harvey, Zhou, White 2006; 166
Streiff, Holmstrom, Angelini 2021; 19
Blom, Doggen, Osanto, Rosendaal 2005; 293
Khorana, Mackman, Falanga 2022; 8
Rosengren, Fredén, Hansson, Wilhelmsen, Wedel, Eriksson 2008; 6
Grilz, Posch, Nopp 2021; 42
bibr11-10760296231158368
Streiff MB (bibr10-10760296231158368) 2021; 19
bibr9-10760296231158368
bibr6-10760296231158368
bibr16-10760296231158368
bibr3-10760296231158368
bibr13-10760296231158368
bibr19-10760296231158368
bibr22-10760296231158368
bibr12-10760296231158368
bibr5-10760296231158368
bibr18-10760296231158368
bibr2-10760296231158368
bibr15-10760296231158368
bibr20-10760296231158368
bibr23-10760296231158368
bibr8-10760296231158368
bibr25-10760296231158368
bibr17-10760296231158368
bibr1-10760296231158368
bibr21-10760296231158368
bibr4-10760296231158368
bibr7-10760296231158368
bibr14-10760296231158368
bibr24-10760296231158368
References_xml – volume: 5
  start-page: 101
  year: 2013
  end-page: 108
  article-title: Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
  publication-title: Clinicoecon Outcomes Res
– volume: 5
  start-page: 927
  issue: 4
  year: 2021
  end-page: 974
  article-title: American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
  publication-title: Blood Adv
– volume: 166
  start-page: 458
  issue: 4
  year: 2006
  end-page: 464
  article-title: Incidence of venous thromboembolism and its effect on survival among patients with common cancers
  publication-title: Arch Intern Med
– volume: 8
  start-page: 11
  issue: 1
  year: 2022
  article-title: Cancer-associated venous thromboembolism
  publication-title: Nat Rev Dis Primers
– volume: 293
  start-page: 715
  issue: 6
  year: 2005
  end-page: 722
  article-title: Malignancies, prothrombotic mutations, and the risk of venous thrombosis
  publication-title: JAMA
– volume: 111
  start-page: 4902
  issue: 10
  year: 2008
  end-page: 4907
  article-title: Development and validation of a predictive model for chemotherapy-associated thrombosis
  publication-title: Blood
– volume: 10
  start-page: 1215
  year: 2018
  end-page: 1221
  article-title: Positive predictive value and misclassification of diagnosis of pulmonary embolism and deep vein thrombosis in Swedish patient registries
  publication-title: Clin Epidemiol
– volume: 11
  start-page: 11639
  issue: 1
  year: 2021
  article-title: Comparison between male and female breast cancer survival using propensity score matching analysis
  publication-title: Sci Rep
– volume: 110
  start-page: 2339
  issue: 10
  year: 2007
  end-page: 2346
  article-title: Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
  publication-title: Cancer
– volume: 84
  start-page: 130
  year: 2017
  end-page: 140
  article-title: Sex differences in cancer risk and survival: a Swedish cohort study
  publication-title: Eur J Cancer
– volume: 24
  start-page: 484
  issue: 3
  year: 2006
  end-page: 490
  article-title: Thromboembolism in hospitalized neutropenic cancer patients
  publication-title: J Clin Oncol
– volume: 119
  start-page: 648
  issue: 3
  year: 2013
  end-page: 655
  article-title: Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States
  publication-title: Cancer
– volume: 6
  start-page: 307
  issue: 1
  year: 2022
  end-page: 320
  article-title: The incidence of cancer-associated thrombosis is increasing over time
  publication-title: Blood Adv
– volume: 49
  start-page: 1404
  issue: 6
  year: 2013
  end-page: 1413
  article-title: Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases
  publication-title: Eur J Cancer
– volume: 343
  start-page: 1846
  issue: 25
  year: 2000
  end-page: 1850
  article-title: Prognosis of cancers associated with venous thromboembolism
  publication-title: N Engl J Med
– volume: 5
  start-page: e008864
  issue: 11
  year: 2015
  article-title: Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study
  publication-title: BMJ Open
– volume: 103
  start-page: 947
  issue: 7
  year: 2010
  end-page: 953
  article-title: Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006
  publication-title: Br J Cancer
– volume: 18
  start-page: 1321
  issue: 12
  year: 2013
  end-page: 1329
  article-title: Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis
  publication-title: Oncologist.
– volume: 137
  start-page: 1959
  issue: 14
  year: 2021
  end-page: 1969
  article-title: Venous thromboembolism in cancer patients: a population-based cohort study
  publication-title: Blood
– volume: 19
  start-page: 1181
  issue: 10
  year: 2021
  end-page: 1201
  article-title: Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology
  publication-title: J Natl Compr Canc Netw
– volume: 9
  start-page: 337
  year: 2015
  end-page: 345
  article-title: Patients’ experiences of living with cancer-associated thrombosis: THE PELICAN study
  publication-title: Patient Prefer Adherence
– volume: 6
  start-page: e12714
  issue: 4
  year: 2022
  article-title: Pulmonary embolism and deep vein thrombosis—comorbidities and temporary provoking factors in a register-based study of 1.48 million people
  publication-title: Res Pract Thromb Haemost
– volume: 42
  start-page: 2299
  issue: 23
  year: 2021
  end-page: 2307
  article-title: Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis
  publication-title: Eur Heart J
– volume: 6
  start-page: 558
  issue: 4
  year: 2008
  end-page: 564
  article-title: Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men
  publication-title: J Thromb Haemost
– volume: 28
  start-page: 2111
  issue: 8
  year: 2019
  end-page: 2124
  article-title: Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries
  publication-title: Qual Life Res
– volume: 19
  start-page: 1181
  issue: 10
  year: 2021
  ident: bibr10-10760296231158368
  publication-title: J Natl Compr Canc Netw
– ident: bibr4-10760296231158368
  doi: 10.2147/PPA.S79373
– ident: bibr2-10760296231158368
  doi: 10.1056/NEJM200012213432504
– ident: bibr20-10760296231158368
  doi: 10.1136/bmjopen-2015-008864
– ident: bibr21-10760296231158368
  doi: 10.1016/j.ejca.2017.07.013
– ident: bibr14-10760296231158368
  doi: 10.1200/JCO.2005.03.8877
– ident: bibr11-10760296231158368
  doi: 10.1016/j.ejca.2012.10.021
– ident: bibr19-10760296231158368
  doi: 10.1182/bloodadvances.2021005590
– ident: bibr25-10760296231158368
  doi: 10.1111/j.1538-7836.2007.02857.x
– ident: bibr12-10760296231158368
  doi: 10.1182/bloodadvances.2020003442
– ident: bibr22-10760296231158368
  doi: 10.1038/s41598-021-91131-4
– ident: bibr9-10760296231158368
  doi: 10.1038/sj.bjc.6605883
– ident: bibr3-10760296231158368
  doi: 10.2147/CEOR.S39964
– ident: bibr15-10760296231158368
  doi: 10.1002/cncr.27772
– ident: bibr17-10760296231158368
  doi: 10.1001/jama.293.6.715
– ident: bibr18-10760296231158368
  doi: 10.1001/archinte.166.4.458
– ident: bibr13-10760296231158368
  doi: 10.1182/blood-2007-10-116327
– ident: bibr5-10760296231158368
  doi: 10.1038/s41572-022-00336-y
– ident: bibr23-10760296231158368
  doi: 10.1002/cncr.23062
– ident: bibr24-10760296231158368
  doi: 10.2147/CLEP.S177058
– ident: bibr6-10760296231158368
  doi: 10.1007/s11136-019-02175-z
– ident: bibr7-10760296231158368
  doi: 10.1002/rth2.12714
– ident: bibr1-10760296231158368
  doi: 10.1182/blood.2020007338
– ident: bibr16-10760296231158368
  doi: 10.1634/theoncologist.2013-0226
– ident: bibr8-10760296231158368
  doi: 10.1093/eurheartj/ehab171
SSID ssj0019696
Score 2.3573954
Snippet Cancer is a risk factor for venous thromboembolism (VTE). We aimed to define sex-specific risk of preceding cancer in patients with a first-time VTE by...
SourceID doaj
swepub
pubmedcentral
proquest
pubmed
crossref
sage
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 10760296231158368
SubjectTerms Brain cancer
Cancer and Oncology
Cancer och onkologi
Carcinoma, Renal Cell
Case-Control Studies
Clinical Medicine
Cross-sectional studies
Epidemiology
Female
Frailty
Health risks
Humans
Kidney cancer
Kidney Neoplasms
Klinisk medicin
Male
Medical diagnosis
Melanoma
Original Manuscript
Pancreatic cancer
Prevalence
Prostate cancer
Retrospective Studies
Sweden - epidemiology
Thromboembolism
Venous Thromboembolism - epidemiology
Venous Thromboembolism - etiology
SummonAdditionalLinks – databaseName: DOAJ (Directory of Open Access Journals)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlh9BLaZN-OE2KCiWFgqlsWbLV23ZpCIWU0iYlNyPZo2Qha4f1LiH_vjO2dhuTkl562IvlFYNmxnqjmXli7B1uQiK3MomNr4s4s87GThWUKSR87XzlUupGPvmmj8-yr-fq_M5VX1QTNtADDwv3UQK6o1KVsq7KqqSwANb52nqd2DwwgQoj1sFUyB8Q50vIYSZ9c3muRWpwq8e5Ckm8qnd2oZ6s_28I836hZGjFH7GK9jvR0VP2JEBIPhlEf8YeQbPDdicNhs_zW37I-6LO_rR8h22fhNz5LlsRW5Pte4x46_mU1L3gs4Z_H6hVO05nsvxXT9rKTy8X7dy1gL-rWTf_xCf8BywX7bozkw-E2jezGnCqDuLpUPPOqTDxlqb9eQP4TXvOzo6-nE6P43DpQlypXCxjkFnq0WklhoayroUD403mTAYVVZyaShV1hqjKpw7BGgDGf_idkimkAhBNePmCbTVtA68Yd0A5SgANJqN-ukIoX-ep0EZJgkIRE2sllFVgJKeLMa7KJJCQ39NbxD5s_nI90HE89PJn0uzmRWLS7h-gfZXBvsp_2VfE9td2UQb37kq64ksjGJY4_HYzjI5J2RbbAOqpTPMCBdI6TyL2cjCjjSTE-o9ACSXMRwY2EnU80swue_JvDI-1ESpi78kU_4j0wCocDtY6mvxidV3io4tV2eEaIE7L9d7_WK7X7HGKMHA4pNpnW8vFCg4Qti3dm95DfwNIITxY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Ra9RAEF60gvgi2qqNVllBKgjBJJvdJL7IeViKUBFt5d5CNpm9HvSSM7mj9N87s9lLDZV7yMsmWTaZmd1vd2a-YewdLkJBUojQz0yV-nGhC1_LlDyFhK-1KXVE2chn39XpRfxtJmfuwK1zYZXbOdFO1FVT0hn5R6qqpBB_iPjz6o9PVaPIu-pKaNxnDyx1GepzMhs2XJb5pY85pEDbTDmvZmjTzRNFTRGxzaSCmFb_WZcsff__MOfd0EmXnD_iGbVr08kT9tiBSj7pteApuwf1PjuY1LihXt7wY27DPO35-T57eOa86QdsQ_xNhc064o3hU1KAli9q_qMnW-04ndLy35bGlZ9fts1SN4DX1aJbfuIT_hPWbbPN1eQ9xfb1ogLsqgN_2kfBcwpVvKFuf10DznLP2MXJ1_Ppqe_KMPilTIK1DyKODJqxwM2iqKpAQ2ayWGcxlBSDmpUyrWLEWSbSCN8AcEeIM5eIIAoA8YURz9le3dRwyLgG8loCKMhiyrBLA2mqBAWbSUHgyGPBVgh56TjKqVTGVR46WvI7cvPYh-GVVU_QsevhLyTZ4UHi1rYNTTvPnanmAnABkLKUhS7jMkwLgEKbqjAqLKgYgMeOtnqRO4Pv8lv19Njb4TaaKvlfihpQTnmUpDggpZLQYy96NRpGQnUAEDrhCJORgo2GOr5TLy4tHThumFUWSI-9J1W8HdKOv3Dca-uo8_lmlWPTfJN3-A8QuSXq5e4vfcUeRQj5-gOpI7a3bjfwGiHaWr-xdvgXBbA0Nw
  priority: 102
  providerName: ProQuest
Title Prevalence of Cancer in Patients with Venous Thromboembolism: A Retrospective Nationwide Case-Control Study in Sweden
URI https://journals.sagepub.com/doi/full/10.1177/10760296231158368
https://www.ncbi.nlm.nih.gov/pubmed/36851858
https://www.proquest.com/docview/2920604534
https://www.proquest.com/docview/2780766671
https://pubmed.ncbi.nlm.nih.gov/PMC9986905
https://gup.ub.gu.se/publication/324276
https://doaj.org/article/3e91155c5abc4c18aeeabfdaf61a7004
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ra9RAEF_6APGLaKs2Wo8VpIIQzXOT-EWuR48itJTzqvctZJPJ9aBJSh6U---dSTaR0FL8cAR2c5thd2b3t_Nk7BMeQoYX2aYepImvO5GMdOn6ZCkkfC3TWFoUjXxxKc6vnZ8rd7XDij4WRs1g9ZXcqpCidrMm6SZt9DdlZMSnJwwrwKMbAY1vC_9HU2dhp-7uq2pQC9mnm4xM2zE5RG71Prxtl-1TMSaU5P3pfPFnORgeKFlM56ZIvrmBUIbQRz86OsrajP-PwdSH3pYqnn-UmrQ9zuYv2QuFQ_m0Y5xXbAfyA3Y4zfEOnm35CW89Q1uV-wF7dqEM8IesoZRPURuoxIuUz4hnSr7J-VWXn7XipNjlv9vMr3x5UxaZLAB_t5sq-86nfAF1WfThnbzLyn2Pc4VDVaDPOsd5Tt6NWxr21z3gxviaXc_PlrNzXVVu0GPXM2odbMdKUfJtvF_aSWJICNLAkYEDMbmtBrHrJw5Cs9SSiPgA8BKJm51tgWUAQpLUfsP28iKHI8YlkKETQEDgUFCeb7hp4lmGCFyb8JTGjH4RwlilNafqGrehqTKZP1g3jX0Z_nLX5fR46uVTWtnhRUrH3TYU5TpU0h3agGeG68ZuJGMnNv0IIJJpEqXCjKh-gMaOe74Iew4PqU6YQERtY_fHoRulm0w2UQ64TqHl-UiQEJ6psbcdGw2UUOkARFtIoTdisBGp4558c9NmEMc7tggMV2OfiRX_kfTELJx03DoafN3chdi0bsIK5wDBnife_feQ79lzCwFjp846Znt12cAHBHi1nLBdb-VNlGji8_Ts8moxadUlfwHqJEtY
linkProvider SAGE Publications
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVIJeELQ8XAosEhQJycLvBxJCaWiV0iaqSlr1Zrz2OI3U2MFOFOVP8RuZ8SMlKsqtB1_W9mrtmZ39dmfmG4D3tAhpbmjqqp_EnmqFMlSl7bGnkPG1TCJpcDZyr-90L6wfV_bVBvxpcmE4rLKxiaWhjrOIz8g_c1Ulh_CHaX2b_Fa5ahR7V5sSGpVanOBiTlu24uvxd5LvB8M4Ohx0umpdVUCNbFebqmhaRkJaadLex4xjTaKf-Jb0LYw4pNKPbC-2CDYkhiQ0gkgbHJqIpoGGhrRcJib1-wA2Lc5obcHmwWH_7Hzpt2CumSrKkUN7faf2o-plgrvrcJPB_Daeydyu_6yEZcGA_6Hcu8GaNR3ACrNpuRoePYHHNYwV7UrvnsIGptuw005pCz9eiH1RBpaWJ_bb8LBX--93YMaMUWGZ5ySyRHRY5XIxSsVZRe9aCD4XFpclcawYXOfZWGZI182oGH8RbXGO0zxrskNFReo9H8VIXRWodqq4e8HBkQvu9uccya4-g4t7EdFzaKVZii9BSGQ_KaKDvsU5fZ5mJ7FLquTbJsMxBbRGCEFUs6JzcY6bQK-J0O_ITYFPy1cmFSXIuocPWLLLB5nNu2zI8mFQG4fARFpybDuyQxlZke6FiKFM4jBx9JDLDyiw1-hFUJuYIridEAq8W94m48AenzBFklNguB4NyHFcXYEXlRotR8KVBwis0QjdFQVbGerqnXR0XRKQ0xbd8TVbgY-sirdDWvMX9ittXel8OJsE1DScBQX9A8KKrrO7_kvfwqPuoHcanB73T17BlkGAszoO24PWNJ_hawKIU_mmnpUCft23IfgL_wtwpg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBdbCmUvY2v34a3bNBgdDLzaliXbe8uyhe6jpXTp1jdj2ac00NjBTij973dnKxmmpewhGCxHHNKd9JPu7neMvcNNyIsy4buJKWI3zHTmahmTp5DwtTa5Digb-ehYHZ6F38_lub1wo1wYO4LNRwqrQonaxZqse1GYA-tjxGekvCDBnRvxTCxUfJ9thVRDd8C2huPTP5ONH4G4X7qoQwq1TZT1a97aSW9nagn8b0OdN4MnbXp-j2m03Z3Gj9hDCyv5sNODx-welDtsd1jikXp-zfd5G-jZ3qDvsO0j60_fZSticMravCNeGT4iFaj5rOQnHd1qw-melv9uiVz55KKu5roC_F3OmvknPuSnsKyrdbYm70i2r2YFYFcNuKMuDp5TsOI1dfvrCnCde8LOxl8no0PXFmJwcxl5SxdEGBg0ZIHHRVEUnobEJKFOQsgpCjXJZVyEiLRMoBHAAeCZENcuEUDgASIMI56yQVmV8JxxDeS3BFCQhJRjF3vSFFHgqUQKgkcO89aTkOaWpZyKZVymviUmvzFvDvuw-cuio-i46-PPNLObD4ldu31R1dPUGmsqALcAKXOZ6TzM_TgDyLQpMqP8jMoBOGxvrRfpWmFTKvulECALbH67aUZjJQ9MVgLOUxpEMQqkVOQ77FmnRhtJqBIAgieUMOopWE_Ufks5u2gJwfHIrBJPOuw9qeI_ke4Yhf1OW3udT1eLFF9NV2mDY4DYLVIv_rvLN2z75Ms4_fnt-MdL9iBAKNhdVO2xwbJewSuEbkv92trnX0w7NmE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+Cancer+in+Patients+with+Venous+Thromboembolism%3A+A+Retrospective+Nationwide+Case-Control+Study+in+Sweden&rft.jtitle=Clinical+and+applied+thrombosis%2Fhemostasis&rft.au=Glise+Sandblad%2C+Katarina&rft.au=Hansson%2C+Per-Olof&rft.au=Philipson%2C+Jacob&rft.au=Mahmoud%2C+Ahmad&rft.date=2023-01-01&rft.eissn=1938-2723&rft.volume=29&rft.spage=10760296231158368&rft_id=info:doi/10.1177%2F10760296231158368&rft_id=info%3Apmid%2F36851858&rft.externalDocID=36851858
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1076-0296&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1076-0296&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1076-0296&client=summon